Evidence map›Paper›PMID 30513630›Full record

ReviewInternational journal of molecular sciences2018

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs.

Kazutaka Ohi, Chika Sumiyoshi, Haruo Fujino, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Tomoko Shiino, Tomiki Sumiyoshi, Ryota Hashimoto

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Current neuropharmacology · 2025
    Review
  11. Article
  12. Review
  13. Genetic overlap between schizophrenia and cognitive performance.Schizophrenia (Heidelberg, Germany) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kazutaka OhiDepartment of Neuropsychiatry, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan. ohi@kanazawa-med.ac.jp.ORCID 0000-0001-9577-9640
Chika SumiyoshiFaculty of Human Development and Culture, Fukushima University, Fukushima 960-1296, Japan. sumiyoshi@educ.fukushima-u.ac.jp.
Haruo FujinoGraduate School of Education, Oita University, Oita 870-1192, Japan. fjinoh@hus.osaka-u.ac.jp.
Yuka YasudaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan. yasuda@psy.med.osaka-u.ac.jp.
Hidenaga YamamoriDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan. yamamori@psy.med.osaka-u.ac.jp.
Michiko FujimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. mfujimoto@psy.med.osaka-u.ac.jp.
Tomoko ShiinoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan. tshiino@ncnp.go.jp.ORCID 0000-0002-8750-0854
Tomiki SumiyoshiDepartment of Preventive Interventions for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan. sumiyot@ncnp.go.jp.ORCID 0000-0001-9629-1671
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan. ryotahashimoto55@ncnp.go.jp.
National Center of Neurology and Psychiatry · JPFukushima University · JPKanazawa Medical University · JPOita University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

General cognitive (intelligence) function is substantially heritable, and is a major determinant of economic and health-related life outcomes. Cognitive impairments and intelligence decline are core features of schizophrenia which are evident before the onset of the illness. Genetic overlaps between cognitive impairments and the vulnerability for the illness have been suggested. Here, we review the literature on recent large-scale genome-wide association studies (GWASs) of general cognitive function and correlations between cognitive function and genetic susceptibility to schizophrenia. In the last decade, large-scale GWASs (

Indexed as

CognitionGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansSchizophreniageneral cognitive functiongenetic correlationGWASintelligenceschizophrenia

Identifiers

PMID30513630
PMCPMC6320986
OpenAlexW2902990444

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.